- Login
- Register & Subscribe
- Langue: EN FR DE
Research & University News
Nobel Prize awarded to cell biology pioneers
Monday 8 October 2012
Two pioneers in cell biology, John Gurdon of the UK and Shinya Yamanaka of Japan, have been awarded the 2012 Nobel Prize in Physiology or Medicine for their work in showing that mature cells can be reprogrammed to become pluripotent.
Location
Sweden
MRC Technology reports on antibody project
Thursday 20 September 2012
A research project supported by MRC Technology of the UK and directed at new treatments for Alzheimer’s disease, has reached an important threshold with the humanisation of a next-generation antibody binding to amyloid beta.
Location
United Kingdom
Brain neurons and diet said to influence obesity
Tuesday 18 September 2012
New research published in the EMBO Journal suggests that a specific type of neuron in the brain can influence the way the body breaks down and stores nutrients, providing further insight into obesity and other metabolic diseases.
Location
Germany
MRC to open up its compound library to researchers
Monday 17 September 2012
Up to 9,000 small-molecule compounds with potential as future drugs are being made available free of charge to academic researchers around the world by MRC Technology, the technology transfer arm of the UK’s Medical Research Council.
Location
United Kingdom
AZ and Broad Institute to work on infection
Monday 10 September 2012
AstraZeneca Plc and the Broad Institute in Cambridge, Massachusetts, US have announced a collaboration to identify new chemical compounds targeting bacterial and viral infections. Financial details were not disclosed.
Location
United Kingdom
Protein’s role in prostate cancer described
Wednesday 15 August 2012
UK scientists have reported new findings on the role of heat shock proteins in the development of prostate cancer which suggest that the p23 protein may act independently to activate the androgen hormones that fuel the cancer’s growth.
Location
United Kingdom
Novartis andUPenn to work on cellular therapies
Monday 6 August 2012
Novartis has announced plans to invest in a new Center for Advanced Cellular Therapies at the University of Pennsylvania in the US to research immunotherapies for patients with cancer using chimeric antigen receptor (CAR) technologies.
Location
Switzerland
Meeting Report: Spotlight on advanced therapies
Friday 13 July 2012
Some 300 clinical trials are underway in Europe testing prospective cell, gene and tissue-engineered therapies. Known as advanced therapy medicinal products (ATMPs), these medicines are being investigated for a broad range of diseases- from macular degeneration to Parkinson’s disease.
Location
Ireland
ThromboGenics, BioInvent give clinical update
Tuesday 5 June 2012
Thrombogenics NV and BioInvent International AB have decided to stop development of an early-stage anticoagulant after safety issues were identified. They have also regained a cancer asset from Roche, which has left the programme.
Location
Belgium
OS data for tasquinimod reported
Monday 4 June 2012
New data from a Phase 2 study of the prostate cancer drug, tasquinimod, show longer median overall survival times than previously reported for this patient population, according to the sponsors, Active Biotech AB and Ipsen SA. The data were reported at Asco.
Location
United States
Select a News Category
Recent Appointments
Steffen Thirstrup joins NDA Group
Monday June 10 2013
Tarquin Bennett-Coles joins Odgers Berndtson
Monday June 10 2013
Sandy Eisen becomes non-executive director at Phosphate Therapeutics
Thursday June 6 2013
Eric-Paul Paques to chair Grünenthal
Thursday June 6 2013
Charles DeCarli joins advisory board at DiaGenic
Thursday June 6 2013